Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries
Recent news and posts
Regular update of the Norwegian Laboratory Code System released
On May 23, 2025, the Norwegian Directorate of Health released an updated version of the Norwegian Laboratory Code (NLK) system (Norsk laboratoriekodeverk 7280.76) and associated tariffs (Laboratoriekodeverk som gir rett til refusjon) for state and private laboratories to be implemented no later than September 1, 2025. NLK system is used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) for laboratory tests performed in outpatient settings.
A total of 55 new codes were added, and 65 codes were changed.
Some examples of newly introduced codes are provided below:
- NOR35351 Spz-HDS-index;
- NPU63168 P-Insulin antibody;
- NPU63194 DNA-CYP21A2-gene (NG_007941.3:g.1-59506);
- NOR35346 F-VRE enriched cultivation;
- NOR35349 Us-LRE enriched cultivation;
- NPU06020 Us-Ceftibuten;
- NPU63167 P-Sink T8 C-terminal antibody;
- NPU63170 P-GAD65 antibody;
The letter at the beginning of the code description stands for sample type: B – blood, F – feces, P - plasma, Spz – sperm, U – urine, Us - unspecified sample.
See the full details here (codes) and here (tariffs).
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.